Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
type: MedicalStudy
description: Open, Prospective Study of the Safety of GSK Biologicals' Boostrix® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) Administered to a Cohort of Adolescents in a US Health Maintenance Organization (HMO)
status: COMPLETED
study design: OBSERVATIONAL
start date: 2006-03
end date: 2006-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00297856
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: GlaxoSmithKline
study subject: Diphtheria
study subject: Tetanus
study subject: Acellular Pertussis
keywords: OBSERVATIONAL
keywords: COMPLETED
keywords: Diphtheria
keywords: Tetanus
keywords: Acellular Pertussis

AI Analytics
type: Organization